136 
Progress  in  Pharmacy. 
/Am.  Jour.  Pnarro. 
1      March,  1908. 
that  are  now  so  manifest.  This  latter  need  appears  to  have  been 
dwelt  upon  at  some  length  at  a  joint  meeting  of  retail  druggists  and 
physicians  recently  held  in  Chicago. 
Another  need  that  has  manifested  itself  is  the  improvement  of 
many  of  the  preparations  enumerated  in  the  National  Formulary  ? 
also  a  few,  at  least,  of  the  preparations  of  the  U.S.P.  This  need  has 
been  recognized  by  the  several  branches  of  the  American  Pharma- 
ceutical Association,  and  a  concerted  attempt  is  now  being  made  to 
institute  investigations  looking  to  the  possible  improvement  of 
U.S.P.  and  N.F.  formulas. 
The  Chicago  branch  has  been  particularly  active  in  this  line  of 
work  and  a  number  of  valuable  suggestions  have  been  brought 
forward  by  members  of  this  branch. 
Discouraging  the  Prescribing  of  Secret  Remedies. — That  the  present 
move  to  discourage  the  use  of  secret  remedies  by  physicians  is 
attracting  the  attention  of  thinking  men  in  all  parts  of  the  world  is 
evidenced  by  the  action  of  the  British  Columbia  Medical  Associa- 
tion. At  the  annual  meeting,  held  in  Victoria,  B.  C,  this  Associa- 
tion adopted  resolutions  deprecating  the  use  and  sale  of  patent 
medicines  and  the  prescribing  of  proprietary  remedies  by  physi- 
cians. 
The  British  Columbia  Medical  Council  was  requested  to  commu- 
nicate with  all  physicians  in  the  province,  drawing  their  attention  to 
the  undesirability  of  prescribing  secret  proprietary  remedies.  {Phar. 
Jour.,  December  7,  1907,  page  769.) 
In  England  the  British  Pharmaceutical  Codex  is  being  made  the 
basis  of  a  concerted  propaganda  on  the  part  of  the  pharmaceutical 
societies.  This  book,  but  recently  published  by  the  Pharmaceutical 
Society  of  Great  Britain,  presents  many  interesting  possibilities  that 
are  well  worth  careful  consideration  on  the  part  of  American  phar- 
macists. 
Proprietary  and  Trade  Names. — Among  the  many  features  of  the 
British  Pharmaceutical  Codex,  the  treatment  that  has  been  accorded 
the  admittedly  complicated  problem  of  proprietary  and  trade  names 
is  perhaps  the  most  interesting.  In  this  connection  an  attempt  has 
been  made  to  introduce  short  and  euphonious  names  for  the  more 
lengthy  chemical  names  for  substances  not  protected  by  patents. 
Among  the  titles  thus  introduced  to  take  the  place  of  trade  names 
we  find  : 
